The 6th General Assembly meeting of ROADMAP was held on the 8th and the 9th of October in Madrid. During the meeting the project outcomes with more impact were presented to the Consortium together with the updates on the final activities.

Glòria Garcia and Carlos Díaz (SYNAPSE) presented ROADMAP’s Data Cube, which offers a ‘landscape’ on dementia data availability (including information from EHR, cohorts and clinical trials). This 3D ‘heat map’ assessment allows the visualisation of different data sources and how they are able to capture the various Alzheimer’s disease-outcomes, together with their relevance for the different disease stages. Engaging discussions were held regarding the usability, sustainability and future upgrades of the tool, which was received with enthusiasm.

ROADMAP, launched on the 1st of November 2016, has been sponsored by the European Union’s Horizon 2020 research and innovation programme and the European pharmaceutical industry (via EFPIA) under the auspices of the Innovative Medicines Initiative 2 Joint Undertaking, and will finalise on the 31st of October 2018.

More about ROADMAP at https://roadmap-alzheimer.org/.